Delivery Order SPE2DB22D3016-SPE2DB25FABD5

Award Date 10/22/24
Potential Completion Date 11/13/24
Potential Value $49K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,746.22 firm-fixed-price delivery order is for the supply of 1,500 units of the KEDRAB 10 ML vial, a pharmaceutical product. The contract has an ultimate completion date of October 4, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,228.80 Firm Fixed Price delivery order contract is for the supply of KEDRAB 300 UNIT/2 ML VIAL 2ML, a medical product. The contract has an ultimate completion date of May 30, 2023. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distribution company Amerisourcebergen Corporation. The $1,945.62 firm fixed-price delivery order is for the procurement of 4,564,542,446 units of the medication KEDRAB, a 2 mL vial. The contract has an ultimate completion date of May 30, 2024. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,325.30 firm fixed-price delivery order is for the supply of KEDRAB 300 UNIT/2 ML VIAL 2ML medical products. The contract has an ultimate completion date of April 9, 2025 and was awarded on March 19, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) for the delivery of KEDRAB, a 300 unit/2 ml vial medication. The $3,990.36 firm fixed price delivery order contract has a completion date of June 25, 2025 and is not set aside. AmerisourceBergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a wide range of...
This federal contract award, with an ID of SPE2DB20D1109 and SPE2DB24FM96F, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,843.20 firm fixed-price delivery order is for the supply of 4,562,564,378 units of the KEDRAB 300 unit/2 ML VIAL 2ML product. The contract has an ultimate completion date of November 14, 2023 and was awarded on October 23, 2023. Amerisourcebergen holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,284.88 firm fixed-price delivery order is for the supply of 1,500 units of the medication KEDRAB, a 10 ML vial. This contract has a period of performance through May 30, 2023 and was awarded on May 8, 2023. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, issued by the Defense Logistics Agency (DLA), was awarded to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, one of the largest pharmaceutical distribution companies. The $1,621.30 firm-fixed-price delivery order is for the supply of 4,564,571,791 units of the KEDRAB 300 unit/2 ML vial 2ML pharmaceutical product. The contract has a completion date of June 3, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,571.22 Firm Fixed Price Delivery Order is for the procurement of 1,500 units of the 10 ML KEDRAB vaccine vial. The award has an ultimate completion date of May 23, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,594.16 Firm Fixed Price delivery order is for the supply of KEDRAB 300 UNIT/2 ML VIAL 2ML, a medical product, with a period of performance ending on March 21, 2024. The contract was awarded on February 29, 2024 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a...
  • SPE2DB22D3016
    Indefinite Delivery Contract
  • SPE2DB22D3016-SPE2DB25FABD5
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $48,639 Firm Fixed Price Delivery Order (SPE2DB22D3016) is for the supply of KEDRAB 300 UNIT/2 ML VIAL 2ML, with an ultimate completion date of November 13, 2024. The contract has no set-aside designation, indicating open competition.

Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also has a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation through May 2024, covering similar medical commodities. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies for military personnel, veterans, and other federal beneficiaries.

Generated 1/22/25, 12:51 AM